ABSTRACT
BACKGROUND: Vitiligo has an unpredictable course and a variable response to treatment. Furthermore, the improvement of some vitiligo lesions cannot be considered a guarantee of a similar response to the other lesions. Instruments for patient-reported outcome measures (PROM) can be an alternative to measure complex constructions such as clinical evolution. OBJECTIVE: The aim of this study was to validate a PROM that allows to measure the clinical evolution of patients with nonsegmental vitiligo in a simple but standardized way that serves to gather information for a better understanding of the disease. METHODS: The instrument was created through expert consensus and patient participation. For the validation study, a prospective cohort design was performed. The body surface area affected was measured with the Vitiligo Extension Score (VES), the extension, the stage, and the spread by the evaluation of the Vitiligo European Task Force assessment (VETFa). Reliability was determined with test-retest, construct validity through hypothesis testing, discriminative capacity with extreme groups, and response capacity by comparing initial and final measurements. RESULTS: Eighteen semi-structured interviews and 7 cognitive interviews were conducted, and 4 dermatologists were consulted. The instrument Clinical Evolution-Vitiligo (CV-6) was answered by 119 patients with a minimum of primary schooling. A wide range was observed in the affected body surface; incident and prevalent cases were included. The average time to answer the CV-6 was 3.08 ± 0.58 min. In the test-retest (n = 53), an intraclass correlation coefficient was obtained: 0.896 (95% CI 0.82-0.94; p < 0.001). In extreme groups, the mean score was 2 (2-3) and 5 (4-6); p < 0.001. The initial CV-6 score was different from the final one and the change was verified with VES and VETFa (p < 0.05, n = 92). CONCLUSIONS: The CV-6 instrument allows patient collaboration, it is simple and brief, and it makes it easier for the doctor to focus attention on injuries that present changes at the time of medical consultation.
Subject(s)
Patient Reported Outcome Measures , Vitiligo/diagnosis , Adolescent , Adult , Age Factors , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Prospective Studies , Reproducibility of Results , Severity of Illness Index , Vitiligo/complications , Vitiligo/therapy , Young AdultABSTRACT
BACKGROUND: Mycobacterium leprae was thought to be the exclusive causative agent of leprosy until Mycobacterium lepromatosis was identified in a rare form of leprosy known as diffuse lepromatous leprosy (DLL). METHODS: We isolated M. lepromatosis from a patient with DLL and propagated it in athymic nude mouse footpads. Genomic analysis of this strain (NHDP-385) identified a unique repetitive element, RLPM, on which a specific real-time quantitative polymerase chain reaction assay was developed. The RLPM assay, and a previously developed RLEP quantitative polymerase chain reaction assay for M. leprae, were validated as clinical diagnostic assays according to Clinical Laboratory Improvement Amendments guidelines. We tested DNA from archived histological sections, patient specimens from the United States, Philippines, and Mexico, and US wild armadillos. RESULTS: The limit of detection for the RLEP and RLPM assays is 30 M. leprae per specimen (0.76 bacilli per reaction; coefficient of variation, 0.65%-2.44%) and 122 M. lepromatosis per specimen (3.05 bacilli per reaction; 0.84%-2.9%), respectively. In histological sections (n = 10), 1 lepromatous leprosy (LL), 1 DLL, and 3 Lucio reactions contained M. lepromatosis; 2 LL and 2 Lucio reactions contained M. leprae; and 1 LL reaction contained both species. M. lepromatosis was detected in 3 of 218 US biopsy specimens (1.38%). All Philippines specimens (n = 180) were M. lepromatosis negative and M. leprae positive. Conversely, 15 of 47 Mexican specimens (31.91%) were positive for M. lepromatosis, 19 of 47 (40.43%) were positive for M. leprae, and 2 of 47 (4.26%) contained both organisms. All armadillos were M. lepromatosis negative. CONCLUSIONS: The RLPM and RLEP assays will aid healthcare providers in the clinical diagnosis and surveillance of leprosy.
Subject(s)
Mycobacterium leprae , Mycobacterium , Animals , Humans , Mexico , Mice , Mycobacterium leprae/genetics , Pathology, MolecularABSTRACT
Psoriasis is an inflammatory autoimmune disease characterized by cutaneous lesions in plaques. It has been proposed that the immune response has a key role in the disease progression. Particularly, the Th17 cells through IL-17 can contribute to maintain the inflammatory process. The pathogenic Th17 phenotype has been described in human diseases and associated with high severity in inflammatory experimental models. However, it is not clear if the pathogenic phenotype could be present in the skin and peripheral blood as well as its possible association to severity in psoriasis. In the lesional skin, we found high infiltration of Th17 cells and the pathogenic phenotype, finding a correlation between the frequency of Th17 cells and the Psoriasis Area and Severity Index (PASI) score. In peripheral blood, we observed a pool of Th17 lymphocytes with potential to acquire pathogenic features. Interestingly, the percentage of pathogenic Th17 cells (CD4+ RORγt+ IFN-γ +) correlates with disease severity. Moreover, we distinguished three groups of patients based on their IL-17/IFN-γ production by Th17 lymphocytes, which seems to be related with a dynamic or stable potential to express these cytokines. Remarkably, we evaluated the cytokine production by Th17 cells as an immunological marker for the adequate selection of biologic therapy. We found that patients analyzed by this immunological approach and treated with antibodies against IL-17 and TNFα showed great improvement depicted by reduction in PASI and Dermatology Life Quality Index (DLQI) score as well as the percentage of Body Surface Area (BSA). Altogether, our results highlight the importance of the assessment of the pathogenic phenotype in Th17 cells as an immune personalized analysis with the potential to support the therapy choice in the clinical practice.
Subject(s)
Psoriasis/metabolism , Th17 Cells/metabolism , Flow Cytometry , Fluorescent Antibody Technique , Humans , Microscopy, Confocal , Psoriasis/blood , Psoriasis/genetics , Skin/metabolism , Tumor Necrosis Factor-alpha/bloodABSTRACT
This systematic review of measurement instruments for vitiligo outcomes included validation articles published from 2011 to May 2018. According to the PRISMA statement, the search was carried out in EMBASE (via OvidSP); MEDLINE (via OvidSP and PubMed). The COSMIN taxonomy will be used to define the measurement properties. Inclusion criteria were original studies reporting measuring properties. Exclusion criteria were clinical trials using scales whose measurement properties were not assessed, studies of cross-cultural adaptation, scales focused on other aspects of the disease such as quality of life, satisfaction, disease's burden. Fourteen studies were identified, which described 15 instruments to measure vitiligo outcomes. Nine of them, measured properties related to the severity of the disease: Vitiligo extent score (VES), Self-Assessment Vitiligo Extent Score (SA-VES), Self-Assessed Vitiligo Area Scoring Index (SAVASI), Vitiligo Area Scoring Index (VASI), Vitiligo European Task Force assessment (VETFa), Vitíligo Noticeability Scale (VNS), Koebner's phenomenon in vitiligo score (K-VSCOR), Vitiligo Extent Tensity Index (VETI), Potential Repigmentation Index (PRI). The most effective tool to asses affected Body Surface Area (BSA) is VES. The VASI is useful to stratify by severity. There is not enough evidence to recommend the use of SAVASI. The VETFa does not offer any difference to calculate the affected BSA compared with the rule of 9's. The VNS and K-VSCOR lack of reliability evidence.
Subject(s)
Severity of Illness Index , Vitiligo , HumansABSTRACT
BACKGROUND: Psoriasis is an autoimmune skin disease that may be associated with articular manifestations, and the most common clinical presentation is the variety "in plaques". In Mexico, in the Centro Dermatológico Pascua, it is the eighth leading cause of consultation. The aim of this study was to determine the diagnostic process of patients in a reference center for diseases of the skin. METHODS: Performing an analytical cross-sectional study that included 100 patients where the diagnostic process was questioned, clinimetric scales were applied and evaluated anthropometric. RESULTS: It was found that 70% of patients had taken over a month to get medical care (median: 3 months; IQR: 11 months), having consulted in 61% to a general physician as a doctor of first contact and 89% being diagnosed by a dermatologist. Eighty-eight percent of the patients were overweight or obese. We found as a factor of delay, a partnership with the variable of having an Institutional Medical Service (p = 0.019; U = 695.5). CONCLUSION: it is necessary to design a system to shorten the diagnostic process, not only in psoriasis, in addition to emphasizing dermatological education.
Subject(s)
Delayed Diagnosis/statistics & numerical data , Psoriasis/diagnosis , Referral and Consultation/statistics & numerical data , Adult , Cross-Sectional Studies , Female , Humans , Male , Mexico , Middle Aged , Obesity/epidemiology , Overweight/epidemiology , Time FactorsABSTRACT
Circumscribed palmoplantar hypokeratosis is a recently described condition with well-defined clinical and histopathologic features. Eight additional cases from Mexican patients-six cases have been published in the literature, we report 7. In 6 cases, a hyperkeratotic edge was demonstrated histologically. One case was very similar to viral wart. Two of our patients had lesions on their fingers. Since palms and soles are not the only sites that can be affected, we suggest the name circumscribed hypokeratosis. Two of the cases were treated with surgical excision, so this treatment for small lesions is recommended.
Subject(s)
Keratoderma, Palmoplantar/pathology , Adolescent , Aged , Aged, 80 and over , Female , Humans , Male , Mexico , Middle AgedABSTRACT
Frontal fibrosing alopecia was recently described by Kossard, et al. as a progressive symmetrical recession of the frontal-temporal-parietal hairline affecting particularly postmenopausal women. Besides affecting the scalp, there are some cases in the literature with partial or total loss of the eyebrows, also involving the trunk, and superior extremities. Because the clinical, histological, and immunochemical findings are indistinguishable from those seen in lichen planopilaris, frontal fibrosing alopecia is now considered a localized variant of lichen planopilaris. We report four cases of Mexican postmenopausal women with this kind of dermatosis evaluated at the Dermatological Center Dr. Ladislao de la Pascua.
Subject(s)
Alopecia/pathology , Alopecia/therapy , Female , Humans , Middle AgedABSTRACT
INTRODUCTION: Acne is considered a multifactorial skin disease secondary to an obstructive process of pilosebaceous units. Some studies suggest a relationship between insulin levels and the presence of acne, but this has not yet been demonstrated. OBJECTIVE: To compare the levels of insulin in patients with and without comedonal acne. MATERIAL AND METHODS: From January to July 2012, we conducted a cross-sectional study in the Dr. Ladislao de la Pascua Dermatologic Center in Mexico city. We recruited men and women from 14 to 25 years old with and without comedonal acne. We measured the insulin levels in all patients with DXI 800 Beckman Coulter equipment in a blood sample. RESULTS: Twenty patients with acne and 20 patients without acne were studied, with an average age of 17 (±3) and 19 (±4) years, respectively. Both groups were different in terms of gender. Body mass index was similar in both groups. We did not find a difference in insulin levels between groups (p=0.818). The average level of insulin was 7.15±4.7 uU/ml for the acne group and 7.85±3.3 uU/mL for the control group. CONCLUSION: Insulin levels are similar in patients with and without comedonal acne. There is no direct relationship between hyperinsulinemia and acne.
Subject(s)
Acne Vulgaris/blood , Insulin/blood , Adolescent , Adult , Cross-Sectional Studies , Female , Humans , Male , Young AdultABSTRACT
Renal tubular acidosis is a disease prevalent in childhood, responsible for a decrease in growth due inadequate acid-base levels regulation. It is well known that systemic conditions can generate or accompany nail changes by different pathophysiologic mechanisms, however no one has ever found or reported any association of onychopathy with renal tubular acidosis so far. That is why we would like to share our experience on this topic.
Subject(s)
Acidosis, Renal Tubular/complications , Nail Diseases/etiology , Child , Child, Preschool , Female , Humans , MaleABSTRACT
Keratinocyte cancer (KC) is the most common cancer worldwide. It is important to analyze the actual interventions that are available for the prevention of patients with a previous history of a KC. We aim to review the existent literature to assess the efficacy and safety of interventions to prevent KC in patients with a history of previous KC. We searched clinical trials in which the main outcome was the prevention of KC in patients with a previous history of KC using the strategy published in the International Prospective Register of Systematic Reviews (PROSPERO registry), CRD42016045981. We analyzed 18 clinical trials from which eight reported a benefit with their respective intervention but had methodological flaws and a variable risk of bias. Two clinical trials (regarding celecoxib and oral supplementation with nicotinamide) seemed to have the most beneficial results reducing the incidence of KC in treated groups. However, all of the studies are highly heterogeneous, which does not allow a meta-analysis to be performed. New studies with greater epidemiological value should be conducted.
Subject(s)
Carcinoma , HumansABSTRACT
Background and Aims: The treatment of recalcitrant facial flat warts has always been challenging for dermatologists. The pain related to the application of the different treatments, side effects and costs are determining factors in the choice of therapy. To date, it is known that oral isotretinoin administered at a dose of 0.5 mg/kg/day is effective and safe; However, the different adverse effects reported have a dose-dependent behavior and they could limit their use. Our aim is to assess the effect of low-doses of oral isotretinoin to reducing side effects in the complete removal of recalcitrant facial flat warts and the current evidence in this regard. Methods: An extensive literature review was conducted to identify articles relating to low doses of oral isotretinoin for recalcitrant flat warts treatment, regardless of design up to May 2023. Results: The literature search yielded eight articles of 324 reviewed meeting criteria. Isotretinoin was administered in doses of 0.1-0.5 mg/kg/day. Complete elimination of the lesions occurred in 65.13% of the patients and a partial response in 19.26%. Four relapses were documented at the 4-month follow-up. The most frequent adverse effect was cheilitis. Conclusion: We might consider low doses of oral isotretinoin for the treatment of recalcitrant facial flat warts in which side effects need to be reduced. However, current published works have several limitations, including small sample sizes, lack of control group and follow-up periods. Larger, randomized, controlled studies are needed to verify the efficacy and safety of different doses of isotretinoin.
ABSTRACT
BACKGROUND: skin cancer is the most frequent malign tumor in the world; the prevalence has been increasing in the last years. There is a sub-register of cases due the majority of them are not cause of death. According to the Histopathological Register of Malign Neoplasm from 2004, the skin cancer occupied the third place of incidence, just preceded by cervical and lung cancer. The aim was to determine the prevalence of skin cancer no melanoma type (epidermoid carcinoma and basal cell carcinoma) and malign melanoma in three Mexican cities. METHODS: an observational, non-intervention epidemiological study based on open screening population was performed. RESULTS: eight cases of skin cancer were detected in 443 subjects examined, seven were females. There were six corresponding to basal cellular cancer and two to malign melanoma; there were three subjects with skin phototype II, two with phototype III and three with phototype IV; 75 % of the patients with diagnosis of skin cancer do not presented previous premalignant lesions. CONCLUSIONS: However, the presence of cancer in suspicious lesions, was significance with an increasing risk of 3.4 times. A limitation of the study was the size of the sample and the heterogeneous population.
Subject(s)
Skin Neoplasms/epidemiology , Adolescent , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Mexico , Middle Aged , Prevalence , Urban Health , Young AdultABSTRACT
INTRODUCTION: Some clinical features have been associated with the progression and remission of alopecia areata (AA). We aim to determine possible prognostic factors in Mexican patients with AA. METHODS: This prospective study of a 1-year follow-up included Mexican patients with a clinical diagnosis of AA. We evaluated disease activity with the SALT score at the first visit and 1-year follow-up; progression, no progression, and remission were defined according to score changes. We used multiple linear regression model to detect factors associated with progression and remission. RESULTS: One hundred and four patients concluded the study. Ninety-seven patients (93.3%) had patchy AA. Fifteen patients showed disease progression and 89 no progression, of which 35 patients had remission. Body hair involvement was related to disease progression and adherence to treatment with disease remission and progression. CONCLUSIONS: Body hair involvement is related to poor prognosis. Adherence to treatment is a modifiable prognostic factor associated with the course of AA in Mexican patients.
ABSTRACT
Keratinocyte cancer (KC) is the most common form of cancer in humans. To our knowledge, no previous publications assessing the methodological quality of clinical trials for the prevention of KC have been recently published. We aim to assess the methodological quality of clinical trials focused on the prevention of KC in high-risk groups not receiving immunosuppressive therapy (NRIT) and propose solutions to improve the design of future trials. We searched clinical trials in which the main outcome was the prevention of KC in high-risk NRIT groups using the strategy published in the International Prospective Register of Systematic Reviews (PROSPERO registry), CRD42016045981. Consolidated Standards of Reporting Trials (CONSORT) criteria and the Cochrane Collaboration risk of bias tool were used to assess methodological quality. We analyzed 23 clinical trials. We found a high risk of attrition and reporting bias in 86.9% and 60.9% of the trials, respectively. Regarding the CONSORT criteria, in at least 40% of the trials, the authors omitted the following information: a description of the trial design, the number of losses and exclusions after randomization, the results of subgroup and adjusted analysis, the estimated effect size and the precision of primary and secondary outcomes. Methodological quality was improved in the recently published clinical trials compared to those published before the CONSORT criteria development. All clinical trials should report in detail the information used to assess potential risks of bias.
Subject(s)
Neoplasms , Humans , Keratinocytes , Systematic Reviews as TopicABSTRACT
BACKGROUND: Psoriatic arthritis (PsA) is the main entity associated with psoriasis (PsO). Consequently, several PsA screening instruments have been developed, most of them are self-administered questionnaires, known as patient-reported outcome measures (PROMs). OBJECTIVE: To identify, summarize, and systematically evaluate the evidence of the content validity of PsA screening PROMs, in patients with PsO, by the dermatologist, based on COSMIN methodology. METHODS: A structured literature search was performed, until June 2019, that included development and/or validation studies of a questionnaire for the screening of PsA in patients with PsO. The evaluation was based on the PROMs' development, relevance, comprehensiveness, and comprehensibility. RESULTS: Eleven PROMs were included in the systematic review with four additional validation studies of the included instruments. Only ToPAS2 (Toronto Psoriatic Arthritis Screen) questionnaire had an adequate content validity. CONTEST (Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis), CEPPA (Center of Excellence for Psoriasis sand Psoriatic Arthritis), and SiPAS (Simple Psoriatic Arthritis Screening questionnaire) qualified as inadequate. CONCLUSIONS: Despite the existence of eleven validated PsA screening PROMs, none were supported by very high-quality evidence of their content validity, which brings the opportunity for the creation of a new proposal PROM for the screening of PsA.
Subject(s)
Arthritis, Psoriatic , Psoriasis , Arthritis, Psoriatic/diagnosis , Humans , Mass Screening , Patient Reported Outcome Measures , Surveys and QuestionnairesABSTRACT
Alopecia areata (AA) is a nonscarring alopecia with an autoimmune etiology, unpredictable course, multiple presentations, and variable psychological distress. We conducted a cross-sectional study which included 126 patients with AA. A complete medical history was documented using the Severity Alopecia Tool (SALT) to assess the severity of the disease, and the following questionnaires were applied to the participants: the Dermatology Life Quality Index (DLQI), Hospital Anxiety and Depression Scale (HADS), Plutchik Suicide Risk Scale, and the Perceived Stress Scale (PSS-14) for adults. The Child Dermatology Life Quality Index (cDLQI) and the Birleson Depression Self-Rating Scale questionnaires were applied for children. Quality of life (QoL) disturbance was detected in 77.6% of adult participants, 65.9% of them had signs of depression or anxiety, and 12.8% were at risk of committing suicide. The PSS-14 average score for adults was 24.5. QoL disturbance was detected in 76.7% of children participants, and 6.3% of them showed signs of depression with the Birleson Depression Self-Rating Scale. We conclude that patients with AA could experience changes in their QoL and signs of depression, anxiety, and suicide risk, mainly in the adult population, during the course of the disease.
ABSTRACT
Vulgar psoriasis is an inflammatory cutaneous-systemic disease, chronic and intermittent. Its etiology is not defined, and it has a higher risk of comorbidities which affect the patients' quality of life. The objectives of this trial were establishing the concordance between Guía de Práctica Clínica (GPC) of the plaque psoriasis pharmacological treatment and the clinical practice of a group of Mexican dermatologists, experts in the psoriasis topical treatment; as well as weighing up the interest and knowledge of quality of life and adherence to treatment. A Delphi questionnaire was applied to 30 experts to explore their therapeutic behavior and attitudes toward the assessment of quality of life and treatment adherence. A meeting was held with a subgroup of 10 dermatologists to analyze the results. A second questionnaire was responded to distinguish the decisions taken for topical treatment in institutional and private practice, as well as other items unexplored in the first questionnaire. After analyzing the questionnaires results, it was clear that the data published in the Guía de Práctica Clínica and the prescriptive attitude of the experts are consistent with respect to the topical treatment for plaque psoriasis. There is also agreement on the attitude about drug prescriptions between the physicians in the private and institutional medical care, although in the private practice it is more common to use vitamin D analogues and corticosteroids and the salicylic acid replaces corticosteroids in the institutions.
La psoriasis vulgar es una enfermedad inflamatoria cutáneo-sistémica, de evolución crónica e intermitente, sin etiología definida y con mayor riesgo de comorbilidades que afectan la calidad de vida de los pacientes. Los objetivos del estudio fueron conocer la concordancia entre las guías de práctica clínica (GPC) del tratamiento farmacológico de la psoriasis en placas y la práctica clínica de un grupo de dermatólogos mexicanos expertos en el tratamiento tópico de la psoriasis, así como ponderar el interés y el conocimiento de la calidad de vida y el apego a tratamiento. Se aplicó un cuestionario Delphi a 30 expertos para explorar su conducta terapéutica tópica y las actitudes hacia la evaluación de la calidad de vida y el apego al tratamiento. Se realizó una reunión con un subgrupo de 10 dermatólogos para analizar los resultados. En una reunión se contestó un segundo cuestionario y se resolvieron las discrepancias para la toma de decisiones en tratamiento tópico en los ámbitos privado e institucional, así como algunos otros temas no explorados en la primera etapa. Al analizar los resultados de las encuestas, se encontró que existe concordancia entre lo publicado en la GPC y la conducta prescriptiva de los expertos en lo referente al tratamiento tópico de la psoriasis en placas. En cuanto a la conducta de prescripción entre la práctica privada y la institucional se encontraron puntos de coincidencia, excepto que en la primera se prefiere utilizar análogos de vitamina D y corticosteroides, mientras que en la segunda, el ácido salicílico sustituye a los corticosteroides.
Subject(s)
Attitude of Health Personnel , Dermatologic Agents/administration & dosage , Guideline Adherence/statistics & numerical data , Practice Patterns, Physicians'/statistics & numerical data , Psoriasis/drug therapy , Administration, Cutaneous , Delphi Technique , Dermatologic Agents/therapeutic use , Dermatology , Humans , Medication Adherence , Mexico , Practice Guidelines as Topic , Quality of LifeABSTRACT
Resumen Objetivo: Conocer la prevalencia de las conductas exposición y protección solar en un grupo de adolescentes y compararlos con un grupo de adultos en la Ciudad de México. Material y métodos: Estudio transversal descriptivo en estudiantes de 16 a 18 años y en adultos mayores de 18 años. Resultados: Se encuestaron 748 alumnos, 60 % mujeres y 40 % hombres. El 90 % busca la sombra, el 70.1 % evita exponerse al sol de las 10 a las 16 horas y el 30.6 % usa filtro solar. De 620 adultos, 67.5 % mujeres y 32.4 % hombres, el 82.6 % buscan la sombra, el 60.2 % evita el sol de las 10 a las 16 horas y el 48.1 % utiliza filtro solar. El 72.9 % de adultos y el 80.8 % de adolescentes se exponen al sol debido a actividades domésticas. Discusión: Existe una tendencia similar en las conductas de protección y exposición solar en adolescentes y adultos. Es alta la prevalencia de uso de fotoprotector en adultos en comparación con los adolescentes.
Abstract Objective: To know the prevalence of sun exposure and protection behaviors in a group of adolescents and to compare them with a group of adults in Mexico City. Material and methods: Descriptive, cross-sectional study in students aged 16 to 18 years and in adults older than 18 years. Results: Seven-hundred and forty-eight students were surveyed; 60 % were females and 40 % males; 90 % seek shade, 70.1 % avoid exposing themselves to the sun from 10.00 to 16.00 hours and 30.6 % use sunscreen. Out of 620 adults, 67.5 % were women and 32.4 % were men; 82.6 % seek shade, 60.2 % avoid the sun from 10.00 to 16.00 hours and 48.1% use sunscreen; 72.9 % of adults and 80.8 % of adolescents are exposed to the sun due to domestic activities. Discussion: There is a similar trend in sun protection and exposure behaviors in adolescents and adults. The prevalence of sunscreen use in adults is high in comparison with adolescents.
Subject(s)
Humans , Male , Female , Adolescent , Adult , Middle Aged , Young Adult , Radiation Protection/methods , Sunlight/adverse effects , Sunscreening Agents/administration & dosage , Health Behavior , Students/statistics & numerical data , Time Factors , Cross-Sectional Studies , Health Surveys , Age Factors , MexicoABSTRACT
UNLABELLED: Abstract Background: Recalcitrant facial flat warts are caused by human papillomavirus and may persist for years despite treatment. Isotretinoin has demonstrated benefits in the treatment of recalcitrant, genital and common warts, but placebo-controlled trials have not been performed. OBJECTIVE: To determine whether isotretinoin is safe and effective for recalcitrant facial flat warts. METHODS: Isotretinoin 30 mg/day or placebo was administered to 16 and 15 patients, respectively, in double-blind, randomized fashion for 12 weeks. Cutaneous lesions were assessed and adverse events including serologic and ophthalmologic changes were recorded. It is considered that warts were recalcitrant if the patient was treated for at least 3 years with at least three of the following options: retinoids, 5-fluorouracil, imiquimod and cryotherapy using liquid nitrogen. RESULTS: Each patient in the istotretinoin group showed complete clearance of all flat warts, while none of the patients in the placebo group showed any improvement (p=0.0001). The most frequent adverse event was cheilitis. There were no statistically significant changes in the laboratory findings. LIMITATIONS: The study design does not permit complete blinding of the dermatologist who can easily recognize the adverse effects of isotretinoin. The clinical findings, however, were so dramatic that this would not have impacted the findings. Another limitation of the study is a lack of follow-up to assess for recurrence after the drug was discontinued. CONCLUSIONS: Isotretinoin is an effective treatment for recalcitrant flat facial warts with a well-known, manageable safety profile.